GSK Pharmaceuticals to host analyst meet on August 3, 2026

GlaxoSmithKline Pharmaceuticals has announced it will host an analyst and institutional investor meeting on August 3, 2026. The meeting is being conducted pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The interaction aims to provide updates to the investor community based on information already available in the public domain.

The meeting is categorized as a group interaction and will be held in a digital format. Ajay Nadkarni, Vice President – Administration, Real Estate & Company Secretary, signed the intimation sent to the stock exchanges on July 21, 2026.

Meeting Details

The company provided the following specifics regarding the upcoming interaction:

Date of Meeting	Interaction with	Type	Place of meeting
August 3, 2026	Investors/Analysts Meet	Group	Digital

GlaxoSmithKline Pharmaceuticals noted that the schedule is subject to changes due to exigencies on the part of the investors or the company.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.95%	+3.56%	+6.07%	+10.30%	-19.64%	+56.15%

GlaxoSmithKline Pharmaceuticals Limited has approved a dividend of Rs 57 per share for the financial year ended March 31, 2026, at its 101st Annual General Meeting (AGM). The meeting, held on June 30, 2026, through video conferencing, saw shareholders adopt the audited financial statements and ratify the remuneration for the cost auditor for FY26 and FY27. All six resolutions listed in the notice dated May 13, 2026, were passed with the requisite majority.

Voting Results

The voting process was conducted via remote e-voting from June 26, 2026, to June 29, 2026, and through e-voting during the AGM. P. N. Parikh of Parikh & Associates served as the scrutinizer. The total number of shareholders on the record date of June 23, 2026, was 132,132.

Resolution Summary

Sr No	Agenda	Resolution Type	Result
1	Adoption of Audited Financial Statements for FY26	Ordinary	Passed with requisite majority
2	Dividend of Rs 57 per share for FY26	Ordinary	Passed with requisite majority
3	Re-appointment of Director Mr. Subesh Williams	Ordinary	Passed with requisite majority
4	Commission to Independent Directors	Special	Passed with requisite majority
5	Ratification of Cost Auditor Remuneration for FY26	Ordinary	Passed with requisite majority
6	Ratification of Cost Auditor Remuneration for FY27	Ordinary	Passed with requisite majority

Shareholder Participation

A total of 142,505,574 votes were polled on the resolution regarding the ratification of the cost auditor's remuneration for FY26. The Promoter and Promoter Group cast 127,054,524 votes in favour across all resolutions. Public Institutions and Public Non-Institutions also participated, with votes cast in favour exceeding 99% for most items.